Tsutomu Ota Takeda Pharmaceutical Company Limited

Mr. Ota has been with Takeda Pharmaceutical Company Limited since 1994 in the Pharmaceutical Technology Development Laboratory, responsible for the dosage from design and formulation development. Since 2004, he has been leading several project teams responsible for manufacturing facility construction design and start-up, NDA submissions, and domestic/international CMOs management including on-site audits as a manager of commercial/IMPs QA unit.

Today, Mr. Ota manages the Quality Assurance group that is responsible for the parenteral IMP facilities and aseptic operation, in addition to the non-parenteral dosage forms and APIs.